Cell Therapeutics (CTIC)

Add to Watchlists Create an Alert
1.24 +0.02  +1.64%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Cell Therapeutics Cash from Investing Quarterly:

-0.972M for March 31, 2013
View Full Chart

Cell Therapeutics Cash from Investing Quarterly Chart

    Cell Therapeutics Historical Cash from Investing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -0.972M
    Dec. 31, 2012 -0.971M
    Sept. 30, 2012 -1.619M
    June 30, 2012 -17.90M
    March 31, 2012 -0.214M
    Dec. 31, 2011 -0.725M
    Sept. 30, 2011 -0.78M
    June 30, 2011 -0.84M
    March 31, 2011 -0.327M
    Dec. 31, 2010 -1.126M
    Sept. 30, 2010 -0.108M
    June 30, 2010 0.065M
    March 31, 2010 -1.107M
    Dec. 31, 2009 -0.336M
    Sept. 30, 2009 -0.068M
    June 30, 2009 9.114M
    March 31, 2009 13.13M
    Dec. 31, 2008 4.902M
    Sept. 30, 2008 5.896M
    June 30, 2008 -6.559M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Cash From Investing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
    Learn More

    Get data for

    CTIC Cash from Investing Quarterly Benchmarks

    Companies
    3SBio
    Dendreon 33.25M
    Biogen Idec 155.94M

    CTIC Cash from Investing Quarterly Rankings

    Overall 74th percentile
    1958 of 7600
    Sector 49th percentile
    328 of 653 in Healthcare
    Industry 39th percentile
    143 of 238 in Biotechnology

    CTIC Cash from Investing Quarterly Range, Past 5 Years

    Minimum -17.90M Jun 2012
    Maximum 13.13M Mar 2009
    Average -0.0271M